Credit Suisse’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2
Closed -$7 3320
2022
Q4
$7 Sell
2
-28,306
-100% -$121K ﹤0.01% 3775
2022
Q3
$113K Sell
28,308
-307
-1% -$1.58K ﹤0.01% 3409
2022
Q2
$128K Buy
+28,615
New +$207K ﹤0.01% 3472

Other funds holding SRTA

Credit Suisse's SRTA Position: Q1 2023 in Review

Credit Suisse sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 2 shares — an estimated $7 sold.

Credit Suisse first reported a position in SRTA in Q2 2022 and held it in 3 quarters. The position peaked at $128K in Q2 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Credit Suisse reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 2 Strata Critical Medical Inc shares in Q1 2023, an estimated $7.
  • Credit Suisse first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's Strata Critical Medical Inc position peaked at $128K in Q2 2022.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.